₹-0.40
(Market cap
₹85 Cr
Recently Viewed
Clear AllMarket cap
₹85 Cr
Revenue (TTM)
₹50 Cr
P/E Ratio
16.2
P/B Ratio
2.4
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹5 Cr
ROE
13.3 %
ROCE
18.3 %
Industry P/E
47.25
EV/EBITDA
10.9
Debt to Equity
0.1
Book Value
₹63
EPS
₹10.7
Face value
10
Shares outstanding
5,701,104
CFO
₹0.81 Cr
EBITDA
₹0.22 Cr
Net Profit
₹8.17 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Choksi Asia
| 39.6 | 13.0 | 29.5 | 102.3 | 37.6 | 46.0 | 14.4 |
|
BSE Healthcare
| 2.8 | 5.2 | 8.2 | 4.9 | 24.7 | 13.9 | 11.2 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Choksi Asia
| 10.6 | 56.8 | 24.9 | 5.1 | 196.0 | 7.4 | -30.2 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Choksi Asia
|
149.2 | 85.1 | 49.6 | 5.3 | 11.7 | 13.8 | 16.2 | 2.4 |
| 1,397.8 | 23,415.8 | 2,662.8 | 533.1 | 22.9 | 24.1 | 44.3 | 9.1 | |
| 665.3 | 26,623.2 | 3,626.9 | 315.0 | 15.0 | 13.3 | 88.5 | 11.5 | |
| 581.0 | 1,881.8 | 766.3 | 80.5 | 15.7 | 8.9 | 23.4 | 2.0 | |
| 249.3 | 336.6 | 166.7 | 7.2 | 3.9 | 3.9 | 35.7 | 1.2 | |
| 478.8 | 9,933.1 | 1,566.5 | 169.5 | 14.8 | 12.7 | 59 | 6.6 | |
| 282.6 | 895.6 | 1,231.3 | 29.1 | -4.7 | 4 | 34.4 | 1.3 | |
| 280.8 | 1,468.9 | 294.1 | 32.4 | 17.4 | 15.1 | 44.1 | 6.2 | |
| 404.4 | 6,431.1 | 792.3 | 135.5 | 23.5 | 26.4 | 46.7 | 9.6 | |
| 1,114.1 | 10,760.2 | 768.1 | 159.9 | 29.2 | 19.3 | 67.5 | 11.9 |
No Review & Analysis are available.
Choksi Imaging Limited manufactures and sells photosensitized materials, medical X-ray films, and other products for the healthcare industry primarily in India. It offers ultrasound and colordropller products, such as cardiovascular, and eSaote... compact color and doppler, as well as portable black and white, and other general imaging products; X-ray films and chemicals, which include laser green, laser blue, and laser chemical products; and X-ray accessories, including screens, cassettes, illuminators, and aprons. The company also provides non-destructive testing (NDT) films and chemicals. In addition, it offers NDT services for petrochemical, aerospace, nuclear, and other industrial divisions. Choksi Imaging Limited was founded in 1992 and is based in Mumbai, India. Read more
Incorporated
1992
Chairman
Krishna Kumar
Managing Director
Samir Choksi
Headquarters
Mumbai, Maharashtra
Website
Looking for more details about Choksi Asia Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Choksi Asia Ltd is ₹149.20 (BSE) as of 29-Apr-2026 IST. Choksi Asia Ltd has given a return of 37.57% in the last 3 years.
The P/E ratio of Choksi Asia Ltd is 16.18 times as on 29-Apr-2026, a 66 discount to its peers’ median range of 47.25 times.
The P/B ratio of Choksi Asia Ltd is 2.37 times as on 29-Apr-2026, a 70 discount to its peers’ median range of 8.02 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
12.52
|
1.23
|
|
2024
|
0.00
|
1.54
|
|
2023
|
0.00
|
1.08
|
|
2022
|
0.00
|
0.95
|
|
2021
|
4.44
|
0.49
|
The 52-week high and low of Choksi Asia Ltd are Rs 212.90 and Rs 70.25 as of 29-Apr-2026.
Choksi Asia Ltd has a market capitalisation of ₹ 85 Cr as on 29-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Choksi Asia Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.